Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07623902 · ClinicalTrials.gov registry record · NA
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
A NA study, sponsored by Jubaan.
- Recruiting
- Registry status
- NA
- Development phase
- 1,436
- Enrollment target
NCT07623902: Recruiting NA study, sponsored by Jubaan.
NCT07623902 is a NA study that is actively recruiting participants, run by Jubaan. The registered enrollment target is 1,436 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07623902, a NA study, is actively recruiting participants, sponsored by Jubaan.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,436 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if the Gixam device effectively identifies persons with pre-cancer or cancer in the colon and rectum in adults aged 45-84 that are of average risk to develop colorectal cancer and have received a negative result on a Fecal Immunochemical Test (FIT). The main questions it aims to answer are: 1. Is the Gixam Device effective in identifying persons with pre-cancer or cancer in the colon and rectum that have received a negative FIT result? 2. Is the use of the Gixam device safe? Gixam test result will be compared to the findings of a standard of care screening colonoscopy. Study participants will: 1. Undergo the Gixam test 2. Take a FIT at home and ship to a laboratory. 3. Undergo a standard of care screening colonoscopy.
Primary Outcome
Number of device-related adverse events and serious adverse events.
Interventions
- DIAGNOSTIC_TEST FIT
- DEVICE Gixam System
- PROCEDURE Standard of care screening colonoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,436 participants |
| Start Date | 2026-05-18 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07623902 shows while recruiting
NCT07623902 is an interventional study that assigns participants to a tested intervention. Its 1,436 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which FIT is the first listed.
NCT07623902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07623902 about?
NCT07623902 is a clinical study titled "Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population". The goal of this clinical trial is to learn if the Gixam device effectively identifies persons with pre-cancer or cancer in the colon and rectum in adults aged 45-84 that are of average risk to develop colorectal cancer and have received a negative result on a Fecal Immunochemical Test (FIT). The ma...
What is the current status of trial NCT07623902?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,436 participants. The study started on 2026-05-18. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07623902?
The interventions under investigation include: FIT (DIAGNOSTIC_TEST), Gixam System (DEVICE), Standard of care screening colonoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT07623902?
This trial is sponsored by Jubaan, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07623902's enrollment target sits among peer trials
1,436 70th of 2000 higher than 1,931 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI